# Genetic Testing to Understand and Address Renal Disease Disparities

> **NCT02234063** · NA · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 2052 (actual)

## Conditions studied

- Hypertension
- Chronic Kidney Disease
- Genomics

## Interventions

- **OTHER:** Immediate Genetic Testing

## Key facts

- **NCT ID:** NCT02234063
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-01-12
- **Final completion:** 2018-01-12
- **Target enrollment:** 2052 (ACTUAL)
- **Last updated:** 2020-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234063, "Genetic Testing to Understand and Address Renal Disease Disparities". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02234063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
